| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/31/2006 | US6992070 Treating tissue with phosphodiesterase inhibitor compound and administering exogenous nucleic acid |
| 01/31/2006 | US6991936 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/31/2006 | US6991928 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/31/2006 | US6991920 Peptide for use in human therapeutics and diagnostics |
| 01/31/2006 | US6991917 Spatially directed ejection of cells from a carrier fluid |
| 01/31/2006 | US6991901 Administering an antibody to the polypeptide sec1; angiogenesis inhibitors |
| 01/31/2006 | US6991899 transgenic mink lung cells (which express human furin) which show increased sensitivity to infection or are capable of enhanced productivity of infectious virion; drug screening; kits; vaccines |
| 01/31/2006 | US6991897 Contacting population of cells with detectable substrate for aldehyde dehydrogenase under conditions that ALDH converts substrate to detectable product retained by cells, wherein stem cells have higher concentration of detectable product |
| 01/31/2006 | US6991794 FRIL family of factors and nucleic acids encoding the same; use as therapeutics for alleviating and/or reducing the hematopoietic progenitor cell-depleting activity of many cancer therapeutics |
| 01/31/2006 | US6991787 expanding cells in culture, transfecting cells with an exogenous gene, and cryopreserving the cells; suitable for use in transplantation and gene therapy; storage stability |
| 01/31/2006 | US6991628 Device and method for creating a vascular graft in vitro |
| 01/31/2006 | CA2406381C Maize cellulose synthases and uses thereof |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/31/2006 | CA2339483C Maize cellulose synthases and uses thereof |
| 01/26/2006 | WO2006010161A2 In vitro wound healing assay and device |
| 01/26/2006 | WO2006010020A2 T cell hybridomas |
| 01/26/2006 | WO2006009731A1 Methods of using apo2l receptor agonists and nk cell activators |
| 01/26/2006 | WO2006009533A1 Anti-glycated cd59 antibodies and uses thereof |
| 01/26/2006 | WO2006009309A1 Galectin 9-binding protein factor |
| 01/26/2006 | WO2006009297A1 Construction of chimera using es cells |
| 01/26/2006 | WO2006009291A1 Method of inducing the differentiation of mesenchymal stem cell into odontoblast cell |
| 01/26/2006 | WO2006009241A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PRECURSOR CELL MARKER |
| 01/26/2006 | WO2006008748A2 Porous plasma protein matrices and methods for preparation thereof |
| 01/26/2006 | WO2006008582A1 Treatment of neurological disorders with hematopoeitic growth factors |
| 01/26/2006 | WO2006008548A2 Binding molecules |
| 01/26/2006 | WO2006008401A2 Composition containing a photosynthetic marine and/or fresh-water microorganism culture medium and/or |
| 01/26/2006 | WO2006008074A1 Gene therapy of solid tumours by means of retroviral vectors pseudotyped with arenavirus glycoproteins |
| 01/26/2006 | WO2006007864A1 Treating neurodegenerative conditions |
| 01/26/2006 | WO2005118809A3 Methods and compositions for enhancing cell adhesion properties |
| 01/26/2006 | WO2005116214A3 Destructive insect-inducible promoters and uses thereof |
| 01/26/2006 | WO2005112959A3 Use of umbilical cord blood stem cells to treat ischemic event |
| 01/26/2006 | WO2005097979A3 Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof |
| 01/26/2006 | WO2005086595A3 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 01/26/2006 | WO2005055979A3 Ph triggerable polymeric particles or films containing a poly (beta-amino ester) |
| 01/26/2006 | WO2005040398A3 Methods for preserving nucleated mammalian cells |
| 01/26/2006 | WO2004104178A3 Efficient haploid cell sorting for flow cytometer systems |
| 01/26/2006 | WO2004087885A3 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 01/26/2006 | US20060021095 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 01/26/2006 | US20060021094 Transgenic plant comprising vector expressing glyphosate resistance-conferring decarboxylase gene (GDC2) gene; glyphosate tolerant crops |
| 01/26/2006 | US20060021093 GDC-1 genes conferring herbicide resistance |
| 01/26/2006 | US20060021091 Maize bZIP transcription factors and genes encoding the same and use thereof |
| 01/26/2006 | US20060021089 Methods for modifying plant characteristics |
| 01/26/2006 | US20060021087 Compositions and methods for control of insect infestations in plants |
| 01/26/2006 | US20060021085 Method for producing transgenic plants having an elevated vitamin E content by modifying the serine-acetyltransferase content |
| 01/26/2006 | US20060021084 Production of peroxidase from plant cell and callus cultures |
| 01/26/2006 | US20060021083 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/26/2006 | US20060021082 Cytokinin oxidase sequences and methods of use |
| 01/26/2006 | US20060021081 Soybean cultivar S030136 |
| 01/26/2006 | US20060021080 Soybean cultiver 927013 |
| 01/26/2006 | US20060021076 Prenatal screening |
| 01/26/2006 | US20060021073 Noc2 knockout mouse |
| 01/26/2006 | US20060021071 Cell in which genome is modified |
| 01/26/2006 | US20060021031 Method and system for preventing fraudulent activities |
| 01/26/2006 | US20060020123 Gene encoding a protein having aurone synthesis activity |
| 01/26/2006 | US20060020119 Monoclonal antibodies to gastrin hormone |
| 01/26/2006 | US20060020115 Given amino acid sequence; testing substance's ability to interact with complex; mutants used in crop protection and/or soil treatment |
| 01/26/2006 | US20060020114 Apo-2DcR |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019924 used in neuroblastoma therapy and diagnosis |
| 01/26/2006 | US20060019899 EphA2 T-cell epitopes and uses therefor |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019394 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019391 bioreactor for initiation of cell growth and for cultivation of cells in high densities |
| 01/26/2006 | US20060019390 Patterning substrate and cell culture substrate |
| 01/26/2006 | US20060019389 Porous plasma protein matrices and methods for preparation thereof |
| 01/26/2006 | US20060019387 Liver stem cell |
| 01/26/2006 | US20060019386 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| 01/26/2006 | US20060019385 Apparatus and methods for producing and using high-density cells and products therefrom |
| 01/26/2006 | US20060019384 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system |
| 01/26/2006 | US20060019383 Chemical inhibitors of mismatch repair |
| 01/26/2006 | US20060019378 Cell culture device and manufacturing method thereof |
| 01/26/2006 | US20060019365 IKK-alpha proteins, nucleic acids and methods |
| 01/26/2006 | US20060019362 cells are embedded in a charged polymer that is complex coacervating with an oppositely charged polymer within biologic compatible scaffolds; polymer complex embedding the cells is forming an ultra thin membrane on the surface of the three dimensional scaffold |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019342 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/26/2006 | US20060019340 for diagnosing a rheumatoid disease; rheumatoid arthritis and psoriatic arthritis |
| 01/26/2006 | US20060019338 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 01/26/2006 | US20060019337 Dual expression vector system and screening methods |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019329 Method of screening for protein inhibitors and activators |
| 01/26/2006 | US20060019326 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019316 Apparatus and method for automated protein design |
| 01/26/2006 | US20060019309 Self-assembling peptide surfaces for cell patterning and interactions |
| 01/26/2006 | US20060019307 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | US20060019283 Common marmoset-derived HPRT gene and use thereof |
| 01/26/2006 | US20060019275 Nucleic acids encoding proteins involved in sensory transduction |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019256 Compositions and methods for treating and diagnosing cancer |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060019237 In vitro wound healing assay and device |
| 01/26/2006 | US20060019236 Membrane fusion assay |
| 01/26/2006 | US20060018941 System and method for injecting liquid drug containing biological material |
| 01/26/2006 | US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1 |
| 01/26/2006 | US20060018922 therapeutic uses of rbosCD14 both as an inhibitor of activation which occurs in an acute inflammatory response and as a sensitizer of bovine mammary ductal epithelial cells resulting in leukocyte recruitment and initiation of immune response |
| 01/26/2006 | US20060018906 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis |
| 01/26/2006 | US20060018905 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |